IBDEI0MC ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10200,0)
 ;;=L60.4^^68^664^88
 ;;^UTILITY(U,$J,358.3,10200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10200,1,3,0)
 ;;=3^Beau's Lines
 ;;^UTILITY(U,$J,358.3,10200,1,4,0)
 ;;=4^L60.4
 ;;^UTILITY(U,$J,358.3,10200,2)
 ;;=^5009237
 ;;^UTILITY(U,$J,358.3,10201,0)
 ;;=L60.5^^68^664^290
 ;;^UTILITY(U,$J,358.3,10201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10201,1,3,0)
 ;;=3^Yellow Nail Syndrome
 ;;^UTILITY(U,$J,358.3,10201,1,4,0)
 ;;=4^L60.5
 ;;^UTILITY(U,$J,358.3,10201,2)
 ;;=^5009238
 ;;^UTILITY(U,$J,358.3,10202,0)
 ;;=L60.8^^68^664^168
 ;;^UTILITY(U,$J,358.3,10202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10202,1,3,0)
 ;;=3^Nail Disorders NEC
 ;;^UTILITY(U,$J,358.3,10202,1,4,0)
 ;;=4^L60.8
 ;;^UTILITY(U,$J,358.3,10202,2)
 ;;=^5009239
 ;;^UTILITY(U,$J,358.3,10203,0)
 ;;=L62.^^68^664^169
 ;;^UTILITY(U,$J,358.3,10203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10203,1,3,0)
 ;;=3^Nail Disorders in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,10203,1,4,0)
 ;;=4^L62.
 ;;^UTILITY(U,$J,358.3,10203,2)
 ;;=^5009241
 ;;^UTILITY(U,$J,358.3,10204,0)
 ;;=L64.9^^68^664^33
 ;;^UTILITY(U,$J,358.3,10204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10204,1,3,0)
 ;;=3^Androgenic Alopecia,Unspec
 ;;^UTILITY(U,$J,358.3,10204,1,4,0)
 ;;=4^L64.9
 ;;^UTILITY(U,$J,358.3,10204,2)
 ;;=^5009249
 ;;^UTILITY(U,$J,358.3,10205,0)
 ;;=L65.9^^68^664^231
 ;;^UTILITY(U,$J,358.3,10205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10205,1,3,0)
 ;;=3^Nonscarring Hair Loss,Unspec
 ;;^UTILITY(U,$J,358.3,10205,1,4,0)
 ;;=4^L65.9
 ;;^UTILITY(U,$J,358.3,10205,2)
 ;;=^5009252
 ;;^UTILITY(U,$J,358.3,10206,0)
 ;;=L70.0^^68^664^6
 ;;^UTILITY(U,$J,358.3,10206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10206,1,3,0)
 ;;=3^Acne Vulgaris
 ;;^UTILITY(U,$J,358.3,10206,1,4,0)
 ;;=4^L70.0
 ;;^UTILITY(U,$J,358.3,10206,2)
 ;;=^5009268
 ;;^UTILITY(U,$J,358.3,10207,0)
 ;;=L70.1^^68^664^1
 ;;^UTILITY(U,$J,358.3,10207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10207,1,3,0)
 ;;=3^Acne Conglobata
 ;;^UTILITY(U,$J,358.3,10207,1,4,0)
 ;;=4^L70.1
 ;;^UTILITY(U,$J,358.3,10207,2)
 ;;=^5009269
 ;;^UTILITY(U,$J,358.3,10208,0)
 ;;=L70.3^^68^664^5
 ;;^UTILITY(U,$J,358.3,10208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10208,1,3,0)
 ;;=3^Acne Tropica
 ;;^UTILITY(U,$J,358.3,10208,1,4,0)
 ;;=4^L70.3
 ;;^UTILITY(U,$J,358.3,10208,2)
 ;;=^5009270
 ;;^UTILITY(U,$J,358.3,10209,0)
 ;;=L70.5^^68^664^2
 ;;^UTILITY(U,$J,358.3,10209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10209,1,3,0)
 ;;=3^Acne Excoriee des Jeunes Filles
 ;;^UTILITY(U,$J,358.3,10209,1,4,0)
 ;;=4^L70.5
 ;;^UTILITY(U,$J,358.3,10209,2)
 ;;=^5009272
 ;;^UTILITY(U,$J,358.3,10210,0)
 ;;=L70.8^^68^664^4
 ;;^UTILITY(U,$J,358.3,10210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10210,1,3,0)
 ;;=3^Acne NEC
 ;;^UTILITY(U,$J,358.3,10210,1,4,0)
 ;;=4^L70.8
 ;;^UTILITY(U,$J,358.3,10210,2)
 ;;=^87239
 ;;^UTILITY(U,$J,358.3,10211,0)
 ;;=L70.9^^68^664^7
 ;;^UTILITY(U,$J,358.3,10211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10211,1,3,0)
 ;;=3^Acne,Unspec
 ;;^UTILITY(U,$J,358.3,10211,1,4,0)
 ;;=4^L70.9
 ;;^UTILITY(U,$J,358.3,10211,2)
 ;;=^5009273
 ;;^UTILITY(U,$J,358.3,10212,0)
 ;;=L71.0^^68^664^235
 ;;^UTILITY(U,$J,358.3,10212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10212,1,3,0)
 ;;=3^Perioral Dermatitis
 ;;^UTILITY(U,$J,358.3,10212,1,4,0)
 ;;=4^L71.0
 ;;^UTILITY(U,$J,358.3,10212,2)
 ;;=^5009274
 ;;^UTILITY(U,$J,358.3,10213,0)
 ;;=L71.1^^68^664^259
 ;;^UTILITY(U,$J,358.3,10213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10213,1,3,0)
 ;;=3^Rhinophyma
 ;;^UTILITY(U,$J,358.3,10213,1,4,0)
 ;;=4^L71.1
